{"id":"W2802999705","doi":"10.17925/usn.2018.14.1.47","title":"Edaravone in Amyotrophic Lateral Sclerosis’Lessons from the Clinical Development Program and the Importance of a Strategic Clinical Trial Design","year":2018,"lang":"en","type":"article","venue":"touchREVIEWS in Neurology","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Mitsubishi Tanabe Pharma Corporation; Mallinckrodt Pharmaceuticals","keywords":"Edaravone; Amyotrophic lateral sclerosis; Medicine; Clinical trial; Drug development; Clinical study design; Cohort; Disease; Intensive care medicine; Oncology; Pharmacology; Internal medicine; Drug","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.131096,0.0006891697,0.002152228,0.0007930089,0.0006168461,0.003603487,0.002062977,0.004704923,0.00180035],"category_scores_gemma":[0.09495792,0.0004069407,0.001785334,0.0009729397,0.003744541,0.003960671,0.002501948,0.007506285,0.0004803689],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003178928,"about_ca_system_score_gemma":0.0140293,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001090639,"about_ca_topic_score_gemma":0.002084128,"domain_scores_codex":[0.9442729,0.0456265,0.003846706,0.001476738,0.004028655,0.0007484742],"domain_scores_gemma":[0.8904079,0.09041123,0.003768638,0.003525733,0.009089971,0.002796448],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002974491,0.0003010648,0.001374785,0.01328246,0.001082469,0.0003847956,0.0006159689,0.001418485,0.001547717,0.09246378,0.05497918,0.8295748],"study_design_scores_gemma":[0.007781409,0.005356706,0.004489246,0.03265109,0.002187116,0.001107815,0.000520397,0.001900034,0.002578026,0.1231251,0.8181364,0.0001665767],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"commentary","genre_scores_codex":[0.004112294,0.8041633,0.01345484,0.1629479,0.009306047,0.0009690125,0.0001714936,0.00009553372,0.00477963],"genre_scores_gemma":[0.07207469,0.6738924,0.08426763,0.149527,0.0126125,0.004147642,0.0003421573,0.0001463647,0.0029896],"genre_candidate":"commentary","genre_consensus":null,"teacher_disagreement_score":0.131096,"threshold_uncertainty_score":0.6933101,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.4502577553450474,"score_gpt":0.4830974873236365,"score_spread":0.03283973197858914,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}